173 related articles for article (PubMed ID: 24407706)
1. [Syndromic abdominal ganglioneuroma: a rare cause of false-positive findings in the F-18 FDG PET / CT in neurofibromatosis type 1].
Derlin T; Hagel C; Mautner VF
Rofo; 2014 Jul; 186(7):706-7. PubMed ID: 24407706
[No Abstract] [Full Text] [Related]
2. [Detection of pulmonary tumor thrombosis by integrated 18F-FDG PET/CT scans with intravenous contrast].
Valls E; Garcia JR; Rodriguez R; Soler M; Moragas M; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):49-51. PubMed ID: 23177345
[No Abstract] [Full Text] [Related]
3. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
4. Extensive peritoneal and pleural lymphomatosis in a patient with Burkitt lymphoma revealed with 18F-FDG PET/CT.
Uslu L; Sen F; Sager S; Halaç M
Nuklearmedizin; 2013; 52(5):N56-7. PubMed ID: 24085460
[No Abstract] [Full Text] [Related]
5. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off.
Salamon J; Veldhoen S; Apostolova I; Bannas P; Yamamura J; Herrmann J; Friedrich RE; Adam G; Mautner VF; Derlin T
Eur Radiol; 2014 Feb; 24(2):405-12. PubMed ID: 24097302
[TBL] [Abstract][Full Text] [Related]
7. Giant thoracic ganglioneuroma in a pediatric patient: staging and restaging with ¹⁸F-FDG PET-CT.
Agarwal KK; Sharma P; Kc SS; Bal C; Kumar R
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):310-1. PubMed ID: 25017382
[No Abstract] [Full Text] [Related]
8. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2013 May; 49(5):449-53. PubMed ID: 23321549
[TBL] [Abstract][Full Text] [Related]
10. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
Klumpp B; Schwenzer NF; Gatidis S; Koenigsrainer I; Koenigsrainer A; Beckert S; Mueller M; Claussen CD; Pfannenberg C
Rofo; 2014 Apr; 186(4):359-66. PubMed ID: 24683168
[TBL] [Abstract][Full Text] [Related]
11. False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1.
Shahid KR; Amrami KK; Esther RJ; Lowe VJ; Spinner RJ
J Surg Orthop Adv; 2011; 20(2):132-5. PubMed ID: 21838076
[TBL] [Abstract][Full Text] [Related]
12. Schwannomatosis/neurofibromatosis type 2 associated multiple schwannomas visualized on FDG-PET/CT.
Beylergil V; Haque S; Carver A; Bilsky MH; Carrasquillo JA
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):275-6. PubMed ID: 23582492
[No Abstract] [Full Text] [Related]
13. [Diffuse increased FDG uptake of the atrial myocardium in the PET-CT as a result of irradiation-induced afterload].
Meissnitzer T; Hergan K; Meissnitzer MW
Rofo; 2015 Jul; 187(7):593-4. PubMed ID: 25750120
[No Abstract] [Full Text] [Related]
14. Utility of hCRH-stimulated (18) F-FDG PET-CT scan in localisation of pituitary microadenoma in Cushing's disease.
Patt HP; Lele V; Lila A; Bandgar T; Shah N
J Med Imaging Radiat Oncol; 2014 Apr; 58(2):213. PubMed ID: 24690246
[No Abstract] [Full Text] [Related]
15. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
16. Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers.
Gaeta CM; Vercher-Conejero JL; Sher AC; Kohan A; Rubbert C; Avril N
Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):352-66. PubMed ID: 24322792
[TBL] [Abstract][Full Text] [Related]
17. FDG PET/CT of primary bone tumors.
Costelloe CM; Chuang HH; Madewell JE
AJR Am J Roentgenol; 2014 Jun; 202(6):W521-31. PubMed ID: 24848845
[TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT: normal variations and benign findings--translation to PET/MRI.
Beheshti M; Kim CK
PET Clin; 2014 Apr; 9(2):xiii-xiv. PubMed ID: 25030290
[No Abstract] [Full Text] [Related]
19. Desmoplastic melanoma: true positive and false negative findings on F-18 FDG-PET/CT.
Roarke MC; Nguyen BD; Pockaj BA
Clin Nucl Med; 2008 Aug; 33(8):562-4. PubMed ID: 18645380
[No Abstract] [Full Text] [Related]
20. [¹⁸F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers: a literature review.
Hildebrandt MG; Kodahl AR; Teilmann-Jørgensen D; Mogensen O; Jensen PT
PET Clin; 2015 Jan; 10(1):89-104. PubMed ID: 25455882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]